Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20173666 | 0.84 | CYP3A4 (0.49) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL11287718 | 0.84 | CYP3A4 (0.49) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL20173665 | 0.84 | CYP3A4 (0.49) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL31533207 | 0.82 | MGLL (0.49) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL138018 | 0.81 | LMNA (0.59) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL28543835 | 0.81 | MGLL (0.50) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL29617429 | 0.81 | MGLL (0.50) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL28545053 | 0.81 | MGLL (0.50) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL11288097 | 0.81 | MGLL (0.50) | MGLLLMNAPOLBALDH1A1 | |
| SCHEMBL29316654 | 0.80 | LMNA (0.49) | MGLLLMNAPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240244954-A1 | QUANTUM DOT LIGAND, QUANTUM DOT-LIGAND SYSTEM AND QUANTUM DOT MATERIAL | Beijing Boe Technology Development Co., Ltd. (CN) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240244954-A1 | QUANTUM DOT LIGAND, QUANTUM DOT-LIGAND SYSTEM AND QUANTUM DOT MATERIAL | CDYL, CD2, CDYL2 | MGLL 4683/4885LMNA 4655/4885POLB 4453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.